Sun Pharma Company Profile

Aggregated data from the web about Sun Pharma

Company Name	Sun Pharma
Website	https://www.sunpharma.com
Snippet	Sun Pharma is COMMITTED TO ENSURE un-interrupted supply of medicines to support COVID-19 PANDEMIC RESPONSE KNOW MORE. EVOLUTION OF SUN From humble beginnings in 1983 to a brand trusted worldwide WATCH OUR VIDEO. WORLD's 4th LARGEST Speciality Generic PHARMACEUTICAL COMPANY READ ABOUT SUN PHARMA.
ISIN	INE044A01036
Type	Public
Founded	1983
Founder	Dilip Shanghvi
Revenue	₹334,734 million (US$4.7 billion) (2020)[1]
Website	www.sunpharma.com
Industry	Pharmaceuticals
Products	Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health
Traded as	BSE: 524715, NSE: SUNPHARMA, BSE SENSEX Constituent, NSE NIFTY 50 Constituent
Key people	Dilip Shanghvi (CEO)
Net income	₹37,649 million (US$530 million) (2020)[1]
Area served	Worldwide
Headquarters	Mumbai, Maharashtra, India
Total assets	₹682,524 million (US$9.6 billion) (2020)[1]
Total equity	₹491,246 million (US$6.9 billion) (2020)[1]
Operating income	₹50,095 million (US$700 million) (2020)[1]
Number of employees	36,000 (2020)[1]

Sun Pharma is part of the India company list

Sun Pharma is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.